An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
Meningitis is an inflammation of the meninges, which are the three membranes that cover the brain and the spinal cord; which occurs when the fluid surrounding the meninges becomes infected. Meningitis is a life-threatening disease, particularly in older people and immunocompromised cases. The est...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ResearchersLinks, Ltd
2021-12-01
|
| Series: | Novel Research in Microbiology Journal |
| Subjects: | |
| Online Access: | https://nrmj.journals.ekb.eg/article_208181_0ec3bc9542b93c446f2640089e0c26ca.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849411280727703552 |
|---|---|
| author | Asmaa Alrobai Jehan Alrahimi Sahar El Hadad |
| author_facet | Asmaa Alrobai Jehan Alrahimi Sahar El Hadad |
| author_sort | Asmaa Alrobai |
| collection | DOAJ |
| description | Meningitis is an inflammation of the meninges, which are the three membranes that cover
the brain and the spinal cord; which occurs when the fluid surrounding the meninges becomes
infected. Meningitis is a life-threatening disease, particularly in older people and
immunocompromised cases. The estimated annual numbers of meningitis cases in the
industrialized countries are about 4-6 cases per 100,000 people. Meningococcal disease is
caused by the bacterium Neisseria meningitides, which have A; C, Y, and W-135 serogroups.
Immunization helps to protect the humans from infection, such as the meningococcal vaccine
that protects from infection by A; C, Y, and W-135 serogroups. Meningococcal conjugate
vaccines improve the immunogenicity potential, to prevent meningococcal disease. Several
previous studies have documented the decrease in post-vaccination effectiveness induced by
the meningococcal vaccines. However, effectiveness requires revaccination after a period of
time from the first vaccination. The purposes of this article were to provide an overview of the
meningitis disease, and demonstrate the effectiveness of the meningococcal conjugate vaccine. |
| format | Article |
| id | doaj-art-605ef116cd0d48e29dfc11d00e0835c7 |
| institution | Kabale University |
| issn | 2537-0286 2537-0294 |
| language | English |
| publishDate | 2021-12-01 |
| publisher | ResearchersLinks, Ltd |
| record_format | Article |
| series | Novel Research in Microbiology Journal |
| spelling | doaj-art-605ef116cd0d48e29dfc11d00e0835c72025-08-20T03:34:48ZengResearchersLinks, LtdNovel Research in Microbiology Journal2537-02862537-02942021-12-01561463147910.21608/nrmj.2021.208181An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccineAsmaa Alrobai0Jehan Alrahimi1Sahar El Hadad2Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia Immunology Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaResearch Center of Genetic Engineering and Bioinformatics, VACSERA, Cairo, EgyptMeningitis is an inflammation of the meninges, which are the three membranes that cover the brain and the spinal cord; which occurs when the fluid surrounding the meninges becomes infected. Meningitis is a life-threatening disease, particularly in older people and immunocompromised cases. The estimated annual numbers of meningitis cases in the industrialized countries are about 4-6 cases per 100,000 people. Meningococcal disease is caused by the bacterium Neisseria meningitides, which have A; C, Y, and W-135 serogroups. Immunization helps to protect the humans from infection, such as the meningococcal vaccine that protects from infection by A; C, Y, and W-135 serogroups. Meningococcal conjugate vaccines improve the immunogenicity potential, to prevent meningococcal disease. Several previous studies have documented the decrease in post-vaccination effectiveness induced by the meningococcal vaccines. However, effectiveness requires revaccination after a period of time from the first vaccination. The purposes of this article were to provide an overview of the meningitis disease, and demonstrate the effectiveness of the meningococcal conjugate vaccine.https://nrmj.journals.ekb.eg/article_208181_0ec3bc9542b93c446f2640089e0c26ca.pdfmeningococcalvaccinemeningitisneisseria meningitidesconjugate vaccine |
| spellingShingle | Asmaa Alrobai Jehan Alrahimi Sahar El Hadad An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine Novel Research in Microbiology Journal meningococcal vaccine meningitis neisseria meningitides conjugate vaccine |
| title | An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| title_full | An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| title_fullStr | An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| title_full_unstemmed | An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| title_short | An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| title_sort | overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine |
| topic | meningococcal vaccine meningitis neisseria meningitides conjugate vaccine |
| url | https://nrmj.journals.ekb.eg/article_208181_0ec3bc9542b93c446f2640089e0c26ca.pdf |
| work_keys_str_mv | AT asmaaalrobai anoverviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine AT jehanalrahimi anoverviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine AT saharelhadad anoverviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine AT asmaaalrobai overviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine AT jehanalrahimi overviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine AT saharelhadad overviewofthemeningococcaldiseaseandimpactofthequadrivalentmeningococcalconjugatevaccine |